Alembic Pharmaceuticals reports marginal rise in Q2 consolidated net profit

07 Nov 2023 Evaluate

Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2023 (Q2FY24). 

The company has reported 8.60% fall in its net profit at Rs 133.84 crore for the quarter under review as compared to Rs 146.44 crore for the same quarter in the previous year. However, total income of the company increased by 9.81% at Rs 1,487.79 crore for Q2FY24 as compared to Rs 1,354.88 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 2.41% rise in its net profit at Rs 136.56 crore for Q2FY24 as compared to Rs 133.35 crore for the same quarter in the previous year. Total income of the company increased by 8.79% at Rs 1,605.08 crore for Q2FY24 as compared to Rs 1,475.34 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

1055.00 4.85 (0.46%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.